The toxcast program for prioritizing toxicity testing of environmental chemicals

Toxicological Sciences

Volumn 95, Issue 1, 2007, Pages 5-12

  Dix, David J ^a   Houck, Keith A ^a   Martin, Matthew T ^a   Richard, Ann M ^a   Setzer, R Woodrow ^a   Kavlock, Robert J ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Bioinformatics; Chemo informatics; High throughput screening; Toxicogenomics

Indexed keywords

CARCINOGEN; IMMUNOTOXIN; NEUROTOXIN;

ARTICLE; CELL ASSAY; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; DATA BASE; ENVIRONMENTAL PROTECTION; GOVERNMENT; HEALTH HAZARD; HEALTH PROGRAM; HIGH THROUGHPUT SCREENING; INFORMATION SCIENCE; METABOLOMICS; OUTCOME ASSESSMENT; PHENOTYPE; PHYSICAL CHEMISTRY; PREDICTION; PROCESS DEVELOPMENT; STRUCTURE ACTIVITY RELATION; TOXICITY TESTING; TOXICOGENETICS; UNITED STATES;

ANIMALS; BIOLOGICAL MARKERS; COMPUTATIONAL BIOLOGY; ENVIRONMENTAL POLLUTANTS; GENE EXPRESSION REGULATION; GENOMICS; HUMANS; PROTEOMICS; RISK ASSESSMENT; SYSTEMS INTEGRATION; TOXICITY TESTS; TOXICOLOGY; UNITED STATES; UNITED STATES ENVIRONMENTAL PROTECTION AGENCY;

EID: 33845620001     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfl103     Document Type: Article

References (31)

1. Allen, J. W., Khetani, S. R., and Bhatia, S. N. (2005). In vitro zonation and toxicity in a hepatocyte bioreactor. Toxicol. Sci. 84, 110-119.
2. Austin, C. P., Brady, L. S., Insel, T. R., and Collins, F. S. (2004). NIH Molecular Libraries Initiative. Science 306, 1138-1139.
3. Berg, E. L., Kunkel, E. J., Hytopoulos, E., and Plavec, I. (2006). Characterization of compound mechanisms and secondary activities by BioMAP analysis. J. Pharmacol. Toxicol. Methods 53, 67-74.
4. Bhogal, N., Grindon, C., Combes, R., and Balls, M. (2005). Toxicity testing: Creating a revolution based on new technologies. Trends Biotechnol. 23, 299-307.
5. Borchert, K. M., Galvin, R. J., Frolik, C. A., Hale, L. V., Halladay, D. L., Gonyier, R. J., Trask, O. J., Nickischer, D. R., and Houck, K. A. (2005). High-content screening assay for activators of the Wnt/Fzd pathway in primary human cells. Assay Drug Dev. Technol. 3, 133-141.
6. Bredel, M., and Jacoby, E. (2004). Chemogenomics: An emerging strategy for rapid target and drug discovery. Nat. Rev. Genet. 5, 262-275.
7. Coecke, S.,Ahr, H., Blaauboer, B.J., Bremer, S., Casati, S., Castell, J., Combes, R., Corvi, R., Crespi, C. L., Cunningham, M. L., et al. (2006). Metabolism: A bottleneck in in vitro toxicological test development. The report and recommendations of ECVAM workshop 54. Altern. Lab Anim. 34, 49-84.
8. Ekins, S., Berbaum, J., and Harrison, R. K. (2003). Generation and validation of rapid computational filters for cyp2d6 and cyp3a4. Drug Metab. Dispos. 31, 1077-1080.
9. Fliri, A. F., Loging, W. T., Thadeio, P. F., and Volkmann, R. A. (2005a). Analysis of drug-induced effect patterns to link structure and side effects of medicines. Nat. Chem. Biol. 1, 389-397.
10. Fliri, A. F., Loging, W. T., Thadeio, P. F., and Volkmann, R. A. (2005b). Biological spectra analysis: Linking biological activity profiles to molecular structure. Proc. Natl. Acad. Sci. USA. 102, 261-266.
11. Fliri, A. F., Loging, W. T., Thadeio, P. F., and Volkmann, R. A. (2005c). Biospectra analysis: Model proteome characterizations for linking molecular structures and biological response. J. Med. Chem. 48, 6918-6925.
12. Griffith, L. G., and Swartz, M. A. (2006). Capturing complex 3D tissue physiology in vitro. Nat. Rev. Mol. Cell Biol. 7, 211-224.
13. Gubbels-van Hal, W. M., Blaauboer, B. J., Barentsen, H. M., Hoitink, M. A., Meerts, I. A., and van der Hoeven, J. C. (2005). An alternative approach for the safety evaluation of new and existing chemicals, an exercise in integrated testing. Regul. Toxicol. Pharmacol. 42, 284-295.
14. Janzen, W. P., and Hodge, C. N. (2006). A chemogenomic approach to discovering target-selective drugs. Chem. Biol. Drug Des. 67, 85-86.
15. Kikkawa, R., Fujikawa, M., Yamamoto, T., Hamada, Y., Yamada, H., and Horii, I. (2006). In vivo hepatotoxicity study of rats in comparison with in vitro hepatotoxicity screening system. J. Toxicol. Sci. 31, 23-34.
16. Klekota, J., Brauner, E., Roth, F. P., and Schreiber, S. L. (2006). Using high-throughput screening data to discriminate compounds with single-target effects from those with side effects. J. Chem. Inf. Model 46, 1549-1562
17. Macarron, R. (2006). Critical review of the role of HTS in drug discovery. Drug Discov. Today 11, 277-279.
18. Melnick, J. S., Janes, J., Kim, S., Chang, J. Y., Sipes, D. G., Gunderson, D., James, L., Matzen, J. T., Garcia, M. E., Hood, T. L., et al. (2006). An efficient rapid system for profiling the cellular activities of molecular libraries. Proc. Natl. Acad. Sci. USA. 103, 3153-3158.
19. O'Brien, S. E., and de Groot, M. J. (2005). Greater than the sum of its parts: Combining models for useful ADMET prediction. J. Med. Chem. 48, 1287-1291.
20. O'Brien, P. J., Irwin, W., Diaz, D., Howard-Cofield, E., Krejsa, C. M., Slaughter, M. R., Gao, B., Kaludercic, N., Angeline, A., Bernardi, P., et al. (2006). High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening. Arch. Toxicol. 80, 580-604.
21. Poroikov, V. V., Filimonov, D. A., Ihlenfeldt, W. D., Gloriozova, T. A., Lagunin, A. A., Borodina, Y. V., Stepanchikova, A. V., and Nicklaus, M. C. (2003). PASS biological activity spectrum predictions in the enhanced open NCI database browser. J. Chem. Inf. Comput. Sci. 43, 228-236.
22. Richard, A. M., Gold, L. S., and Nicklaus, M. C. (2006). Chemical structure indexing of toxicity data on the internet: Moving towards a flat world. Curr. Opin. Drug Discov. Dev. 9, 314-325.
23. Scherf, U., Ross, D. T., Waltham, M., Smith, L. H., Lee, J. K., Tanabe, L., Kohn, K. W., Reinhold, W. C., Myers, T. G., Andrews, D. T., et al. (2000). A gene expression database for the molecular pharmacology of cancer. Nat. Genet. 24, 236-244.
24. Schwartz, D. A., Freedman, J. H., and Linney, E. A. (2004). Environmental genomics: A key to understanding biology, pathophysiology and disease. Hum. Mol. Genet. 13, R217-224.
25. Sivaraman, A., Leach, J. K., Townsend, S., Iida, T., Hogan, B. J., Stolz, D. B., Fry, R., Samson, L. D., Tannenbaum, S. R., and Griffith, L. G. (2005). A microscale in vitro physiological model of the liver: Predictive screens for drug metabolism and enzyme induction. Curr. Drug Metab. 6, 569-591.
26. Smith, S. C., Delaney, J. S., Robinson, M. P., and Rice, M. J. (2005). Targeting inputs and optimising HTS for agrochemical discovery. Comb. Chem. High Throughput Screen. 8, 577-587.
27. Tietjen, K., Drewes, M., and Stenzel, K. (2005). High throughput screening in agrochemical research. Comb. Chem. High Throughput Screen. 8, 589-594.
28. Walum, E., Hedander, J., and Garberg, P. (2005). Research perspectives for pre-screening alternatives to animal experimentation - On the relevance of cytotoxicity measurements, barrier passage determinations and high throughput screening in vitro to select potentially hazardous compounds in large sets of chemicals. Toxicol. Appl. Pharmacol. 207, 393-397.
29. Xing, J. Z., Zhu, L., Jackson, J. A., Gabos, S., Sun, X. J., Wang, X. B., and Xu, X. (2005). Dynamic monitoring of cytotoxicity on microelectronic sensors. Chem. Res. Toxicol. 18, 154-161.
30. Yang, Y., Abel, S. J., Ciurlionis, R., and Waring, J. F. (2006a). Development of a toxicogenomics in vitro assay for the efficient characterization of compounds. Pharmacogenomics 7, 177-186.
31. Yang, C., Richard, A. M., and Cross, K. P. (2006b). The art of data mining the minefields of toxicity databases to link chemistry to biology. Curr. Comput. Aided Drug Des. 2, 1-19.